Subscribe
Models
Our Products
Featured Catalog
Humanized Mouse Models
Tool Mice
Custom Model Services
Preclinical Solutions
Resources
About Us
hVSIG4-3xFLAG Mouse
Request a Product Quote
Select products from our catalogs and submit your request. Our team will get back to you with detailed information.
hVSIG4-3xFLAG Mouse
Product Name
hVSIG4-3xFLAG Mouse
Product ID
C002145
Strain Name
C57BL/6Cya-Vsig4em1(hVSIG4-3xFLAG tag)/Cya
Background
C57BL/6Cya
Status
When using this mouse strain in a publication, please cite “hVSIG4-3xFLAG Mouse (Catalog C002145) were purchased from Cyagen.”
Product Type
Age
Genotype
Sex
Quantity
The standard delivery applies for a guaranteed minimum of three heterozygous carriers. Breeding services for homozygous carriers and/or specified sex are available.
+
Standard products are sold as live mice derived from cryorecovery or expansion. Frozen materials are available upon request. Pricing and lead times depend on real-time inventory.
Basic Information
Related Resource
Basic Information
Gene Name
VSIG4
Gene Alias
CRIg, Z39IG
NCBI ID
Chromosome
Chr X (Human)
MGI ID
Datasheet
Strain Description
VSIG4 encodes the V-set immunoglobulin domain-containing protein 4 (also known as CRIg), a type I transmembrane glycoprotein belonging to the B7 family-related immunoregulatory molecules, and serves as the receptor for complement fragments C3b and iC3b. This protein is primarily expressed on tissue-resident macrophages, with high expression on hepatic Kupffer cells, and is also found on splenic, lymph node, and peritoneal macrophages [1]. The extracellular IgV domain of VSIG4 binds C3b/iC3b, acting both as a phagocytic receptor that mediates the uptake of complement-opsonized pathogens and as an inhibitor of alternative pathway C3 and C5 convertase activity, thereby limiting excessive amplification of the complement cascade [1-2]. Recent studies have shown that VSIG4 transmits negative signals by binding to CD5 on the surface of T cells, suppressing T cell proliferation and effector functions [3]. Impaired VSIG4-mediated clearance is associated with susceptibility to bloodstream infections, and its extracellular domain can also directly bind Gram-positive bacteria [4]. In the tumor microenvironment, VSIG4 is highly expressed on Kupffer cells and tumor-associated macrophages, promoting immune evasion by suppressing tumor-specific CD8⁺ T cell responses, and is associated with poor prognosis in various solid tumors [3,5]. VSIG4 possesses dual attributes as both a complement regulator and an immune checkpoint. Anti-VSIG4 antibodies can repolarize tumor-associated macrophages and restore antitumor immunity [6].
The hVSIG4-3xFLAG mouse is a VSIG4 humanized model constructed via gene editing technology, in which the sequences from ATG start codon to partial intron 1 of mouse Vsig4 were replaced with "Kozak-Human VSIG4 CDS-3xFLAG tag-3' UTR of Mouse Vsig4-WPRE-BGH pA" cassette. This model can be used for studying the mechanisms of VSIG4 in infection clearance, complement regulation, and tumor immunity, as well as for screening, development, and preclinical in vivo evaluation of VSIG4-targeted therapies.
Reference
Helmy KY, et al. CRIg: a macrophage complement receptor required for phagocytosis of circulating pathogens. Cell. 2006;124(5):915-927.
Wiesmann C, et al. Structure of C3b in complex with CRIg gives insights into regulation of complement activation. Nature. 2006;444(7116):217-220.
Zhou X, et al. Kupffer cell calibration of T cell responses via VSIG4-CD5 interaction promotes tumor evasion. Nat Immunol. 2026;27(6):1253-1267.
Zeng Z, et al. CRIg Functions as a Macrophage Pattern Recognition Receptor to Directly Bind and Capture Blood-Borne Gram-Positive Bacteria. Cell Host Microbe. 2016;20(1):99-106.
Jung K, et al. VSIG4-expressing tumor-associated macrophages impair anti-tumor immunity. Biochem Biophys Res Commun. 2022;628:18-24.
Sazinsky S, et al. Antibodies Targeting Human or Mouse VSIG4 Repolarize Tumor-Associated Macrophages Providing the Potential of Potent and Specific Clinical Anti-Tumor Response Induced across Multiple Cancer Types. Int J Mol Sci. 2024;25(11).
Strain Strategy
The sequences from ATG start codon to partial intron 1 of mouse Vsig4 were replaced with "Kozak-Human VSIG4 CDS-3xFLAG tag-3' UTR of Mouse Vsig4-WPRE-BGH pA" cassette.

Figure 1. Gene editing strategy of hVSIG4-3xFLAG mice.
Application Area
VSIG4 in Infection Clearance, Complement Regulation, and Tumor Immunity: Mechanisms of Action;
Screening, Development, and Preclinical In Vivo Evaluation of VSIG4-Targeted Therapies.
Related Resource
Contact Us
Connect with our experts for your custom animal model needs. Please fill out the form below to start a conversation or request a quote.
Cyagen values your privacy. We’d like to keep you informed about our latest offerings and insights. Your preferences:
You may unsubscribe from these communications at any time. See our Privacy Policy for details on opting out and data protection.
By clicking the button below, you consent to allow Cyagen to store and process the personal information submitted in this form to provide you the content requested.
